Formation Bio Launches $600 Million Drug Development Accelerator Fund To Boost Clinical Development

Formation Bio introduced its $600 million Drug Development Accelerator Fund to expand its portfolio of promising drug candidates and accelerate clinical development. The fund will invest in individual drug programs rather than standalone biotech companies, licensing assets into newly formed companies that will receive financing and access to Formation Bio’s AI platform, drug development expertise, scientific teams, and operational infrastructure. The initiative aims to address bottlenecks in clinical development, help biotech and pharmaceutical partners advance underfunded drug candidates, and build an enduring, AI-native pharmaceutical company focused on bringing more medicines to patients.

FOUNDERS: Benjamine Liu & Linhao Zhang

AMOUNT: $600,000,000

HQ: New York City, New York

#VentureCapital #FormationBio #BenjamineLiu #LinhaoZhang #TradedVC